Latest Innovations for Treating Disc Degeneration

Latest Innovations for Treating Disc Degeneration

Chronic back pain is considered the number one cause of musculoskeletal disability worldwide. As the fifth most common reason for a physician visit, it affects five out of ten working adults and is responsible for causing 40% of missed days off work. Unfortunately most people will experience acute back pain at some point in their lives.

The most common cause of back pain among younger and middle aged adults is related to tears of the collagen fibers in the disc. These tears by themselves can cause pain, or if a significant number of fibers tear, the disc can bulge and herniate. Bulges and herniation can be a source of irritation or can compress spinal nerves causing “sciatica”. Over time, if the disc does not repair its’ self, it deteriorates and leads to spinal stenosis, or narrowing of the spaces around the spinal nerves and causing pain in the arms or legs.

Up until recently, for patients with injured discs and chronic pain, the only options were to wait and hope the disc heals itself and if not, then treat the symptoms. Recently in sports medicine it was discovered that platelets obtained from the blood and other cells in the bone marrow can be used to repair chronically torn non-healing ligaments and tendons. Dr. Bodor was among the first to utilize these in the Bay Area and, given that he is also an expert on treating the spine, was among the first to use this technique for disc pain. Dr. Bodor described the rationale for the technique and pilot series of patients in a chapter in the textbook, Platelet Rich Plasma (PRP), editor Lana, publisher Springer, 2014 (available on Amazon.com). Dr. Greg Lutz, at the Hospital for Special Surgery in New York City, published positive results for PRP for disc pain in a randomized blinded placebo-controlled trial in the journal PMR in January 2016.

Owing to the relatively low available blood supply in the disc, the introduction of concentrated platelets can seal tears and contribute vital growth and healing factors to facilitate natural repair processes. Dr. Bodor has administered PRP therapy to discs experiencing some degree of degeneration in the lumbar, thoracic and cervical spine. With the support of the Napa Medical Research Foundation, he and Research Assistant Yvette Uribe are carefully monitoring the progress of more than 170 patients to prove the effectiveness of the PRP as a healing agent. The findings thus far yield a minimum 75% improvement rate.

Of special interest is the new technique Dr. Bodor developed during the course of the study. Whenever needles are placed into the neck, a high degree of skill and vigilance is necessary to ensure safety and comfort in doing the procedure. Traditionally such injection procedures are done using x-rays only, but Dr. Bodor developed a technique combining ultrasound and x-rays which allows for better visualization of the carotid arteries, brachial plexus and other vulnerable structures and ensure precise placement into the discs or the cervical facet joints.

Dr. Bodor and his research team were recently asked to write a review article on the evidence for PRP and stem cells in treating chronic painful muscle and ligament injuries. Their work is currently going into publication in Techniques in Regional Anesthesia and Pain Medicine, a peer-reviewed journal published by Elsevier.

Learn More about our clinical studies on Disc Degeneration

 

THE LATEST NEWS: January 2018

WELCOME TO THE BOARD Joann Serafini Ross is a native of Albany, New York and holds a BA in Communications from SUNY, New Paltz, New York. Her varied and diverse career has been filled with hard work and great experiences, all culminating in her current leadership and...

The Development of a New Technique

Innovations and breakthroughs can be the result of years’ worth of effort, multiple failures, and even happy accidents. For Dr. Marko Bodor, it was the driving need to ensure his patients were being diagnosed and treated in the most accurate, timely, effective and...

2017 Accomplishments

The Napa Medical Research Foundation continues to make major contributions in the field of regenerative medicine thanks to our innovative research team, dedicated staff and generous donors. Director of Research, Dr. Marko Bodor, combines his expertise in ultrasound and...

NMRF comments on Wall Street Journal article about stem cell research in U.S.

The recent Wall Street Journal article, “Stem Cells for Knee Injuries? U.S. Doctors Investigate”, presents an important case for the critical research being performed across the country to prove the efficacy of regenerative biologic treatments, including stem cells...

Investing in the Future

 Reduce Pain. Increase Mobility + Function. Improve Quality of Life. All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family...

Napa Valley Marketplace magazine

Dr. Marko Bodor through the Bodor Clinic and the Napa Medical Research Foundation is pioneering new techniques in regenerative medicine to keep patients free of pain and off the operating table. Using the patient’s own red blood cell platelets and stem cells, Dr....

Welcome to the Board, Joann Serafini Ross

Joann Serafini Ross is a native of Albany, New York and holds a BA in Communications from SUNY, New Paltz, New York. Her varied and diverse career has been filled with hard work and great experiences, all culminating in her current leadership and mentoring roles....

Surgery During Harvest

Michael Wolf, owner of Michael Wolf Vineyard Services and long-time Napa Valley grape producer, suffered for years from Carpal Tunnel Syndrome in both wrists.   Like the 12 million other Americans with this condition, Mike was experiencing numbness, tingling, and...

Welcome Dr. Harry Genant

Harry K. Genant, MD, is Professor Emeritus of the University of California San Francisco and currently serves as a Senior Consultant, and past Member of the Board of Directors and Chairman Emeritus of Bioclinica-Synarc, Inc., a global contract research organization he...

Response to British Journal of Sport & Exercise Medicine

The British Medical Journal Open Sports & Exercise Medicine recently published an article titled, “Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leukocyte-rich (type 1a) and leukocyte-poor (type...

Categories

 Reduce Pain. Increase Mobility + Function. Improve Quality of Life.

All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family foundations.

Pin It on Pinterest

Share This